Skip to main content

Table 3 Patient and cancer characteristics by number of lymph nodes removed. Incident non-metastatic colon cancer cases who underwent surgery, Emilia-Romagna, Italy, 2000–2012

From: Colon cancer survival differs from right side to left side and lymph node harvest number matter

Variable

Total

No lymphadenectomy

LN h < 12

LN h 12–21

LN h > 21

P-valuec

N.

N. (%)

N. (%)

N. (%)

N. (%)

23,269

3330

(14.3)

5533

(23.8)

9107

(39.1)

5299

(22.8)

Site

< 0.001

 Left

15,006

2759

(18.4)

4200

(27.9)

5481

(36.5)

2566

(17.1)

 Right

6962

451

(6.5)

992

(14.3)

3127

(44.9)

2392

(34.4)

 Transverse

1301

120

(9.2)

341

(26.2)

499

(38.4)

341

(26.2)

Sex

< 0.001

 Male

12,936

1866

(14.4)

3218

(24.9)

5121

(38.6)

2731

(21.1)

 Female

10,333

1464

(14.2)

2315

(22.4)

3986

(38.6)

2568

(24.9)

(Histological type)

< 0.001

 Carcinoma NOSa

256

204

(79.7)

22

(8.6)

20

(7.8)

10

(3.9)

 Adenocarcinoma

21,142

3053

(14.4)

5109

(24.2)

8247

(39.0)

4733

(22.4)

 Mucinous

1822

69

(3.8)

396

(21.7)

824

(45.2)

533

(29.3)

 Other

49

4

(8.2)

6

(12.2)

16

(32.7)

23

(46.9)

Screening status

< 0.001

 Uninvited

1073

108

(10.1)

237

(22.1)

417

(38.9)

311

(29.0)

 Screen-detected + ICb

4263

631

(14.8)

1059

(24.8)

1667

(39.1)

906

(21.2)

 Non-attendees

2552

282

(11.1)

453

(17.7)

1022

(40.1)

795

(31.2)

Stage

< 0.001

 Stage I

6315

1358

(21.5)

2042

(32.3)

2051

(32.5)

864

(13.7)

 Stage II

7755

65

(0.8)

1721

(22.2)

3622

(46.7)

2347

(30.3)

 Stage III

7174

57

(0.8)

1680

(23.4)

3370

(47.0)

2067

(28.8)

 Unknown

2025

1850

(91.4)

90

(4.4)

64

(3.2)

21

(1.04)

Grade

< 0.001

 G1

2492

657

(26.4)

676

(27.1)

747

(30.0)

412

(16.5)

 G2

13,142

877

(6.7)

3327

(25.3)

5721

(43.5)

3217

(24.5)

 G3–4

4657

256

(5.5)

967

(20.8)

2048

(44.0)

1386

(29.8)

 Unknown

2978

1540

(51.7)

563

(18.9)

591

(19.9)

284

(9.5)

  1. aCarcinoma not otherwise specified
  2. b Interval cancers
  3. cPearson’s chi-squared test